Human TL1A / TNFSF15 Protein, His Tag, active trimer, low endotoxin (MALS verified)

사용자 리뷰
제품 번호/규격
가격
수량
TLA-H5243-100ug
$415.00
TLA-H5243-1mg (500ug X 2)
$3140.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonyms

    TL1A, VEGI, TNFSF15

  • Source

    Human TL1A, His Tag (TLA-H5243) is expressed from human 293 cells (HEK293). It contains AA Leu 72- Leu 251 (Accession # O95150-1).

    Predicted N-terminus: His

    Request for sequence
  • Molecular Characterization

    TL1A Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus.

    The protein has a calculated MW of 22.4 kDa. The protein migrates as 26 kDa and 28-30 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.001 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    TL1A SDS-PAGE

    Human TL1A, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    TL1A SEC-MALS

    The purity of Human TL1A, His Tag (Cat. No. TLA-H5243) is more than 85% and the molecular weight of this protein is around 75-95 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     TL1A ELISA

    Immobilized Human DcR3, Fc Tag (Cat. No. TNB-H5255) at 5 μg/mL (100 μL/well) can bind Human TL1A, His Tag (Cat. No. TLA-H5243) with a linear range of 0.3-5 ng/mL (QC tested).

    Protocol
  •  TL1A ELISA

    Immobilized Human TL1A, His Tag (Cat. No. TLA-H5243) at 2 μg/mL (100 μL/well) can bind pre-mixed increasing concentrations of Monoclonal Anti-TL1A Antibody, Human IgG1 and 4 μg/mL (50 μL/well) Biotinylated Human DR3 Protein, Fc,Avitag (Cat. No. DR3-H82F3) with a half maximal inhibitory concentration (lC50) of 1.976 μg/mL (Routinely tested).

    Protocol
  •  TL1A ELISA

    Immobilized Human TL1A, His Tag (Cat. No. TLA-H5243) at 10 μg/mL (100 μL/well) can bind Human DR3 Protein, Fc Tag (Cat. No. DR3-H5253) with a linear range of 0.005-0.156 μg/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     TL1A SPR

    Human DR3 Protein, His Tag (Cat. No. TN5-H52H3) immobilized on CM5 Chip can bind Human TL1A, His Tag (Cat. No. TLA-H5243) with an affinity constant of 45.8 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  TL1A SPR

    Anti-TL1A antibody captured on Protein A Chip can bind Human TL1A, His Tag (Cat. No. TLA-H5243) with an affinity constant of 0.765 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  TL1A SPR

    Human DcR3, Fc Tag (Cat. No. TNB-H5255) captured on Protein A Chip can bind Human TL1A, His Tag (Cat. No. TLA-H5243) with an affinity constant of 0.269 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  TL1A SPR

    Human TL1A, His Tag (Cat. No. TLA-H5243) captured on CM5 chip via anti-His antibody can bind Human DR3 Protein, Fc Tag (Cat. No. DR3-H5253) with an affinity constant of 1.15 µM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-CELL BASE

     TL1A CELL

    Response to human TL1A protein (FOLD).
    The DR3 (TL1A receptor) (Luc) Jurkat Reporter Cell was stimulated with serial dilutions of human TL1A protein (Cat.No.TLA-H5243). The max induction fold was approximately 40.12.

    Protocol

사용자 리뷰
댓글 남기기

  • S***e2025-09-13
    좋아요
    Worked all times I have used this product with very reproducible data! Also appreciated the very quick shipping.
  • A***e2025-04-10
    좋아요
    I used the TL1A in multiple experiments and the results were always consistent and reproducible. Different lots were used throughout a year long timeline and the results did not differ between lots. When shipping there was not ever any damaged packaging that could impact product quality. I have used Acrobiosystems in my professional career multiple times over multiple years and have always had success :) I will continue to use Acro as a trusted supplier.
  • E***r2024-08-08
    좋아요
    This protein showed good activity in cell reporter assays and could be used routinely in inhibition assays.

배경 소개

TNF-like cytokine 1A (TL1A) and its receptors, death receptor 3 (DR3) and decoy receptor 3 (DcR3) are members of the TNF and TNF receptor superfamilies of proteins, respectively. Binding of APC-derived TL1A to lymphocytic DR3 provides co-stimulatory signals for activated lymphocytes. DR3 signaling affects not only the proliferative activity of and cytokine production by effector lymphocytes, but also critically influences the development and suppressive function of regulatory T-cells. Whereas, DcR3 restricts the function of the TL1A/DR3 complex: attenuating T-cell activation and downregulating the secretion of pro-inflammatory cytokines. Together with DR3 and DcR3, TL1A constitutes a cytokine system that actively interferes with the regulation of immune responses.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Tumor necrosis factor superfamily member 15

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    18 상세

  • 최고 개발 단계:

    Phase 3 Clinical

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호